stockrow
Friday 6 November 2026
Export ESTA’s income statement to Excel — free account
Establishment Labs Holdings Inc.
ESTA Healthcare Medical Devices
Establishment Labs Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $211.1 million, up 27.1% from fiscal 2024.
- Revenue
- +31.7%
- EPS
- +31.6%
- Free cash flow
- +2.75%
- Total debt
- +18.3%
Quarter to June 2026, against a year earlier
67.44
3.02
+4.69%
Follow ESTA
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 2 | 3 | 5 | 5 | 3 | 3 | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
2.73 | 1.46 | 0.05 | 3.30 | 9.89 | 5.76 | 3.54 | 5.70 | — | — |
P/S ratio |
10.23 | 7.81 | 4.12 | 9.49 | 12.79 | 10.36 | 6.34 | 7.77 | 7.97 | 7.97 |
Altman Z″-Score (non-manufacturers) |
(2.10) | (1.65) | (3.04) | (2.20) | (1.61) | 0.79 | (0.71) | 2.36 | (8.39) | (17.06) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(2.30) | (2.40) | (1.84) | (2.64) | (2.70) | (3.22) | (2.79) | (1.57) | (1.99) | — |
P/Operating CF |
(13,325.34) | (62.53) | (83.54) | (109.45) | (210.19) | 255.57 | (141.13) | (56.10) | (42.32) | (42.32) |
P/B ratio |
91.68 | 24.44 | 37.00 | 0.00 | 31.93 | 11.71 | 14.34 | 6.85 | 160.25 | 160.25 |
Price to Tangible BV |
174.15 | 32.27 | 68.46 | 0.00 | 35.30 | 12.48 | 15.91 | 7.26 | 0.00 | 0.00 |
EV/Sales |
11.14 | 8.72 | 5.15 | 10.29 | 12.95 | 10.21 | 6.70 | 7.63 | 8.61 | 8.61 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(46.22) | (24.74) | (9.61) | (31.91) | (59.57) | (69.08) | (20.01) | (13.77) | (12.79) | (12.79) |
EV/FCF |
(40.82) | (19.55) | (7.52) | (19.14) | (47.27) | (63.19) | (15.89) | (11.78) | (12.56) | (12.56) |
Quick Ratio |
1.86 | 2.28 | 1.52 | 2.61 | 2.44 | 4.00 | 2.60 | 4.27 | 0.42 | 0.13 |
Current Ratio |
3.04 | 3.56 | 3.06 | 3.85 | 3.55 | 5.11 | 4.12 | 6.05 | 0.69 | 0.23 |
Net Debt/EBITDA |
(6.03) | (3.05) | (2.47) | (3.09) | 0.08 | 1.54 | (0.38) | 1.44 | 0.57 | (1.37) |
Debt/Assets |
69.30% | 63.31% | 70.26% | 83.13% | 37.20% | 31.86% | 41.31% | 19.15% | 1.05% | 72.09% |
Debt/Equity |
10.51 | 4.14 | 10.26 | (21.44) | 1.02 | 0.66 | 1.22 | 0.32 | (0.12) | (0.81) |
Asset Turnover |
0.60 | 0.54 | 0.69 | 0.92 | 0.86 | 0.62 | 0.77 | 0.70 | 0.80 | 0.46 |
Operating CF/Net income |
1.00 | 0.69 | 1.13 | 0.69 | 0.67 | 0.33 | 0.79 | 1.61 | 0.92 | 0.64 |
Capex/Depreciation |
(0.64) | (2.05) | (5.03) | (8.02) | (1.16) | (0.22) | (2.36) | (0.63) | (0.49) | (17.83) |
Interest Coverage |
(1.54) | (2.40) | (4.22) | (3.37) | (2.77) | (2.98) | (3.56) | (2.71) | (1.92) | (4.64) |
| (133.25%) | (236.67%) | (1,537.75%) | (353.48%) | (65.46%) | (66.54%) | (69.94%) | (65.45%) | 221.93% | 140.92% | |
| (14.51%) | (27.49%) | (32.73%) | (42.90%) | (27.80%) | (27.94%) | (32.73%) | (24.30%) | (80.54%) | (51.14%) | |
ROIC |
(12.47%) | (17.14%) | (24.32%) | (24.56%) | (31.92%) | (43.33%) | (38.60%) | (38.08%) | 0.00% | 0.00% |
Return on Tangible Assets |
(20.98%) | (33.47%) | (40.27%) | (46.41%) | (41.12%) | (31.09%) | (42.86%) | (22.00%) | 766.46% | 76.88% |
Average Days of Receivables |
134.01 | 142.90 | 103.69 | 79.96 | 70.41 | 82.45 | 92.78 | 105.24 | 137.96 | 122.55 |
Research and Development Expense of Revenue |
9.59% | 11.87% | 16.00% | 12.53% | 14.46% | 16.29% | 16.74% | 20.73% | 19.79% | 13.84% |
Selling, General and Administrative Expense of Revenue |
78.20% | 84.21% | 88.15% | 77.91% | 72.80% | 78.68% | 79.06% | 77.27% | 88.87% | 117.11% |
Intangible Assets out of Total Assets |
0.03 | 0.04 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.07 | 0.08 |
Share Based Compensation of Revenue |
5.60% | 9.26% | 9.00% | 8.26% | 8.22% | 6.76% | 7.29% | 11.96% | 9.52% | 15.78% |
Graham Net Nets |
(0.04) | (0.04) | (0.11) | (0.05) | 0.02 | 0.06 | 0.03 | 0.11 | (0.04) | (0.04) |
Graham Number |
0.00 | 0.00 | 0.00 | 4.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(2.39%) | (6.47%) | (11.43%) | (4.89%) | (2.53%) | (4.38%) | (6.72%) | (4.54%) | (14.35%) | (14.35%) |
Free Cash Flow Yield |
(2.67%) | (5.71%) | (16.61%) | (5.67%) | (2.14%) | (1.56%) | (6.64%) | (8.33%) | (8.60%) | (8.60%) |
Revenue per Share |
7.13 | 5.90 | 6.45 | 6.61 | 5.28 | 3.63 | 4.36 | 3.53 | 3.39 | 3.05 |
Operating CF per Share |
(1.72) | (2.08) | (3.46) | (2.13) | (1.15) | (0.54) | (1.46) | (1.95) | (3.12) | (2.20) |
Capex per Share |
(0.23) | (0.55) | (0.96) | (1.42) | (0.30) | (0.05) | (0.38) | (0.10) | (0.09) | (1.63) |
Free Cash Flow per Share |
(1.94) | (2.63) | (4.42) | (3.56) | (1.45) | (0.59) | (1.84) | (2.06) | (3.22) | (3.83) |
Cash per Share |
2.55 | 3.21 | 1.56 | 2.71 | 2.23 | 3.63 | 1.83 | 3.03 | 1.06 | 0.07 |
Shareholders Equity per Share |
0.80 | 1.89 | 0.72 | (0.33) | 2.12 | 3.22 | 1.93 | 4.00 | (0.49) | (4.08) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.80 | 1.89 | 0.72 | (0.33) | 2.12 | 3.22 | 1.93 | 4.00 | (0.49) | (4.08) |
Free Cash Flow |
(57.61) | (74.08) | (113.06) | (86.96) | (34.69) | (13.68) | (37.75) | (35.66) | (32.91) | (24.82) |
Working Capital |
167.80 | 174.76 | 117.75 | 110.95 | 81.38 | 106.40 | 72.60 | 82.99 | (18.05) | (42.05) |
Capital Expenditures |
(6.72) | (15.56) | (24.55) | (34.79) | (7.16) | (1.17) | (7.77) | (1.77) | (0.94) | (10.55) |
Net Current Asset Value |
(83.68) | (50.70) | (75.34) | (69.34) | 24.48 | 50.87 | 18.92 | 52.35 | (22.73) | (43.48) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.09 | 0.15 | 0.22 | 0.06 | 0.01 | 0.09 | 0.03 | 0.03 | 0.53 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.14 | 0.10 | 0.06 | 0.08 | 0.33 | 0.33 | 0.20 | 0.22 | 0.14 | 0.04 |
Cash ROIC |
(16.62%) | (20.41%) | (45.74%) | (37.22%) | (22.23%) | (6.53%) | (30.10%) | (24.69%) | (510.25%) | 534.22% |
Accounts Receivable Turnover |
2.96 | 2.97 | 4.01 | 5.40 | 5.82 | 4.04 | 4.43 | 3.98 | 3.51 | 2.00 |
Accounts Payable Turnover |
1.47 | 1.31 | 1.89 | 3.19 | 3.41 | 3.20 | 4.18 | 3.26 | 2.07 | 1.18 |
Inventory Turnover |
0.79 | 0.71 | 1.00 | 1.70 | 1.60 | 1.24 | 1.30 | 1.32 | 1.89 | 1.08 |
Average Days of Payables |
242.94 | 289.16 | 261.16 | 132.70 | 127.99 | 110.29 | 109.02 | 90.76 | 196.29 | 273.80 |
Days of Inventory on Hand |
482.46 | 508.84 | 498.62 | 242.32 | 251.19 | 263.31 | 301.43 | 361.44 | 283.18 | 180.53 |
Average Receivables |
71.25 | 55.96 | 41.17 | 29.93 | 21.78 | 20.95 | 20.21 | 15.38 | 9.88 | 9.88 |
Average Payables |
43.93 | 43.19 | 30.83 | 17.25 | 12.10 | 10.04 | 8.30 | 7.69 | 8.21 | 8.21 |
Average Inventory |
82.19 | 79.12 | 58.03 | 32.50 | 25.81 | 25.94 | 26.75 | 19.01 | 8.99 | 8.99 |
Average Assets |
352.00 | 307.74 | 239.85 | 175.30 | 147.96 | 136.46 | 116.55 | 86.83 | 43.33 | 43.33 |
Average Common Equity |
38.32 | 35.75 | 5.11 | 21.28 | 62.85 | 57.29 | 54.55 | 32.24 | (15.72) | (15.72) |
Columns are period end dates